Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis?
| Data(s) |
27/01/2015
|
|---|---|
| Formato |
application/pdf |
| Identificador |
http://boris.unibe.ch/75950/1/1-s2.0-S0735109714069435-main.pdf Siontis, George; Windecker, Stephan (2015). Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis? Journal of the American College of Cardiology, 65(3), p. 313. Elsevier 10.1016/j.jacc.2014.10.037 <http://dx.doi.org/10.1016/j.jacc.2014.10.037> doi:10.7892/boris.75950 info:doi:10.1016/j.jacc.2014.10.037 info:pmid:25614435 urn:issn:0735-1097 |
| Idioma(s) |
eng |
| Publicador |
Elsevier |
| Relação |
http://boris.unibe.ch/75950/ |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Siontis, George; Windecker, Stephan (2015). Reply: could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis? Journal of the American College of Cardiology, 65(3), p. 313. Elsevier 10.1016/j.jacc.2014.10.037 <http://dx.doi.org/10.1016/j.jacc.2014.10.037> |
| Palavras-Chave | #610 Medicine & health |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |
